Medscape24d
Potential Targets for Pancreatic Cancer Immunotherapeutics
Muc-1 α-gal epitope (HyperAcute®) NCT00569387 Active, not recruiting II Muc-1 α-gal epitope (HyperAcute®) NCT00614601 Active, not recruiting II Muc-1 α-gal epitope (HyperAcute®) NCT01072981 ...
eLife1mon
Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial
The study by Ma et al. provides fundamental findings and compelling evidence that Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A ...
Frontiers3y
Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells
Protein concentrations were quantified using a bicinchoninic acid assay (BCA) (Pierce Biotechnology ... a key animal model for the translation of immunotherapies. The study of ADCC in rodent syngeneic ...
Frontiers3y
From Toxicity to Selectivity: Coculture of the Fluorescent Tumor and Non-Tumor Lung Cells and High-Throughput Screening of Anticancer Compounds
Six structurally diverse indole, coumarin, sulfonylthiazol, and rifampicin derivatives were found and confirmed with an independent assay (MTT) to be selectively cytotoxic to cancer cells in the ...
eLife4y
Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies
Longitudinal characteristics of heavy and light chain clonal families.